Prevention of Adriamycin‑induced hepatic and renal toxicity in male Balb/c mice by a nutrient mixture

Roomi,M. Waheed; Kalinovsky,Tatiana; Roomi,Nusrath Waheed; Rath,Matthias; Niedzwiecki,Aleksandra

doi:10.3892/etm.2014.1535

Prevention of Adriamycin‑induced hepatic and renal toxicity in male Balb/c mice by a nutrient mixture

Authors:
- M. Waheed Roomi
- Tatiana Kalinovsky
- Nusrath Waheed Roomi
- Matthias Rath
- Aleksandra Niedzwiecki
View Affiliations

Affiliations: Dr. Rath Research Institute, Santa Clara, CA 95050, USA
Published online on: February 11, 2014 https://doi.org/10.3892/etm.2014.1535
Pages: 1040-1044

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adriamycin (ADR), an antineoplastic antibiotic used in cancer therapy, is associated with toxicity to vital organs with long‑term use. A nutrient mixture (NM) has previously been shown to exhibit a broad spectrum of therapeutic properties. The aim of the present study was to determine whether the NM is useful for preventing ADR‑induced hepatic and nephric toxicity. Six‑week‑old male BALB/c mice were divided into four groups of six animals each. Groups A and C were fed a regular diet for three weeks and groups B and D were fed a diet supplemented with 1% NM. After three weeks, the mice in groups C and D received 20 mg/kg body weight ADR intraperitoneally, while those in groups A and B received saline alone. Animals were sacrificed after 24 h, blood samples were collected and serum was obtained for clinical chemistry. Organs were also excised and weighed. Administration of ADR to group C (control diet) resulted in a marked increase in hepatic alanine aminotransferase, aspartate aminotransferase and γ‑glutamyl transferase levels and renal blood urea nitrogen, creatinine and uric acid serum markers. However, in group D (NM 1% diet), the serum markers were comparable with the levels of group A and B. Therefore, the results indicate that NM has the potential to protect against ADR‑induced hepatic and nephric damage.

View Figures

View References

1	Saad SY, Najjar TA and Al-Rikabi AC: The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res. 43:211–218. 2001. View Article : Google Scholar : PubMed/NCBI
2	DeGraff W, Hahn SM, Mitchell JB and Krishna MC: Free radical modes of cytotoxicity of adriamycin and streptonigrin. Biochem Pharmacol. 48:1427–1435. 1994. View Article : Google Scholar : PubMed/NCBI
3	Poli G: Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med. 21:49–98. 2000. View Article : Google Scholar : PubMed/NCBI
4	Loguercio C and Federico A: Oxidative stress in viral and alcoholic hepatitis. Free Radic Biol Med. 34:1–10. 2003. View Article : Google Scholar : PubMed/NCBI
5	Chen Y, Jungsuwadee P, Vore M, Butterfield DA and St Clair DK: Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues. Mol Interv. 7:147–156. 2007. View Article : Google Scholar : PubMed/NCBI
6	Essick EE and Sam F: Oxidative stress and autophagy in cardiac disease, neurological disorders, aging and cancer. Oxid Med Cell Longev. 3:168–177. 2010. View Article : Google Scholar : PubMed/NCBI
7	Feng YQ, Zuo XL, Li RF, Zhang KJ, Chen F and Xiao H: Protection against doxorubicin-induced oxidative damage in normal blood cells by naringenin. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 16:790–793. 2008.(In Chinese).
8	Kasapović J, Pejić S, Stojiljković V, Todorović A, Radošević-Jelić L, Saičić ZS and Pajović SB: Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide. Clin Biochem. 43:1287–1293. 2010.PubMed/NCBI
9	Bouayed J and Bohn T: Exogenous antioxidants - double-edged swords in cellular redox state: Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev. 3:228–237. 2010. View Article : Google Scholar
10	Alshabanah OA, Hafez MM, Al-Harbi MM, Hassan ZK, Al Rejaie SS, Asiri YA and Sayed-Ahmed MM: Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation. Oxid Med Cell Longev. 3:428–433. 2010. View Article : Google Scholar : PubMed/NCBI
11	Venkatesan N, Punithavathi D and Arumugam V: Curcumin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol. 129:231–234. 2000. View Article : Google Scholar : PubMed/NCBI
12	Niedzwiecki A, Roomi MW, Kalinovsky T and Rath M: Micronutrient synergy – a new tool in effective control of metastasis and other key mechanisms of cancer. Cancer Metastasis Rev. 29:529–542. 2010.
13	Roomi MW, Kalinovsky T, Ivanov V, Rath M and Niedzwiecki A: A nutrient mixture prevents acetaminophen hepatic and renal toxicity in ICR mice. Hum Exp Toxicol. 27:223–230. 2008. View Article : Google Scholar : PubMed/NCBI
14	Roomi M, Kalinovsky T, Roomi NW, Ivanov V, Rath M and Niedzwiecki A: A nutrient mixture suppresses carbon tetrachloride-induced acute hepatic toxicity in ICR mice. Hum Exp Toxicol. 27:559–566. 2008. View Article : Google Scholar : PubMed/NCBI
15	Andreadou I, Sigala F, Iliodromitis EK, Papaefthimiou M, Sigalas C, Aligiannis N, Savvari P, Gorgoulis V, Papalabros E and Kremastinos DT: Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress. J Mol Cell Cardiol. 42:549–558. 2007. View Article : Google Scholar
16	Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P and Ramirez-Tortosa MC: New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol. 48:1425–1438. 2010. View Article : Google Scholar : PubMed/NCBI
17	Shimpo K, Nagatsu T, Yamada K, Sato T, Niimi H, Shamoto M, Takeuchi T, Umezawa H and Fujita K: Ascorbic acid and adriamycin toxicity. Am J Clin Nutr. 54(6 Suppl): 1298S–1301S. 1991.PubMed/NCBI
18	Doroshow JH, Locker GY, Ifrim I and Myers CE: Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest. 68:1053–1064. 1981. View Article : Google Scholar : PubMed/NCBI
19	Chen JH, Tipoe GL, Liong EC, So HS, Leung KM, Tom WM, Fung PC and Nanji AA: Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr. 80:742–751. 2004.PubMed/NCBI
20	Hasegawa R, Chujo T, Sai-Kato K, Umemura T, Tanimura A and Kurokawa Y: Preventive effects of green tea against liver oxidative DNA damage and hepatotoxicity in rats treated with 2-nitropropane. Food Chem Toxicol. 33:961–970. 1995. View Article : Google Scholar : PubMed/NCBI
21	Patil LJ, Bothara SB and Balaraman R: Effect of chronic administration of green tea extract on chemically induced electrocardiographic and biochemical changes in rat heart. Int J Green Pharm. 4:170–173. 2010. View Article : Google Scholar
22	Roomi MW, Monterrey JC, Kalinovsky T, Rath M and Niedzwiecki A: Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines. Oncol Rep. 24:747–757. 2010.PubMed/NCBI